CONCURRENT SESSIONS I
From 12:00 to 13:00 (Rooms 2306/2309, 2311, 2314), UBC Nest
"Antibody revolution and technology evolution" | Room 2311
The immune system has evolved over millions of years to fight diseases and infections. Through several mechanisms, B cells generate an immense diversity of antibody molecules, with each B cell producing a different antibody. These defense proteins target and bind precisely to bacteria, viruses, or other foreign molecules, and help the immune system neutralize and destroy pathogens. It is this unique specificity that makes some antibodies extremely potent and low side-effect drugs. Antibodies have been the fastest growing class of therapeutics over the past decade, with approved therapies spanning multiple indications including cancer, autoimmune disorders, inflammation, and infectious diseases. Finding the rare antibodies with therapeutic properties out of the billions produced by an immune system can be challenging. Based on technology originally developed at UBC, AbCellera has built a discovery engine to search through immune repertoires with greater depth than any other platform. Dr. Lecault will share how the technology has evolved to become a leading-edge platform, and how it contributes to accelerating discovery in this new era of immunotherapy.
“From Mustard Gas to Immunotherapy : A survey of anti-cancer therapies” | Room 2306/2309
The evolution of strategies for diagnosing and treating cancer has occurred in conjunction with our growing knowledge of the disease. The use of cytotoxic agents, targeted therapies and drug delivery methods to treat cancer will be discussed. Novel treatments that are being developed will be described.
"TBD" | Room 2314